Description of Collaborative Activity: |
The Somatic Cell Genome Editing (SCGE) program aims to develop quality tools to perform effective and safe genome editing in human patients. These research tools will be made widely available to the research community to reduce the time and cost required to develop new therapies. A representative from FDA/CBER plays an advisory role for the program regarding regulatory issues. The program is also coordinating with the NIST Gene Editing consortium and the DARPA Safe Genes program and is exploring ideas for possible synergistic activities. |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/DPCPSI/ORIP, OD/DPCPSI/OSC |
